Hillstar Bio
United States
- Boston
- 02/04/2025
- Series A
- $67,000,000
Hillstar Bio is a precision immunology company based in Boston's Seaport neighborhood advancing a portfolio of programs against autoimmune diseases with unmet or underserved medical needs.
- Industry Biotechnology Research
- Website https://hillstarbio.com/
- LinkedIn https://www.linkedin.com/company/hillstar-bio/
Related People
Robert MabryFounder
United States -
Cambridge, Massachusetts
Biotechnology leader with extensive experience working across pharma, biotech, and venture- backed startups. Proven ability to lead cross-functional scientific and technology organizations in biologic discovery and development. Successful track record of driving innovative science and strategy to meet milestones from target discovery to IND yielding multiple biologic programs under clinical evaluation and one approval. Experience leading business development and in/out-licensing efforts, managing external collaborations, and building effective teams across multiple organizations.
SPARK Microsystems | $12,364,525 | (Mar 24, 2026)
Meadow Memorials | $9,000,000 | (Mar 24, 2026)
Oryon Cell Therapies | $21,000,000 | (Mar 24, 2026)
Hamilton AI | $7,500,000 | (Mar 24, 2026)
Flourish Care | $5,700,000 | (Mar 24, 2026)
Interloom | $16,500,000 | (Mar 24, 2026)
eternal.ag | $9,271,160 | (Mar 24, 2026)
EGIDE | $9,266,200 | (Mar 24, 2026)
Cleavr | $1,158,600 | (Mar 24, 2026)
JAAQ | $17,416,100 | (Mar 24, 2026)
CisLunar Industries | $2,600,000 | (Mar 24, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)